A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients
Clinical trial NCT01468688 · COMPLETED
Trial details
- NCT number
- NCT01468688
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-20
- Primary completion
- 2016-07-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.